|
1
|
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
|
Am J Cardiol
|
2005
|
2.11
|
|
2
|
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
|
Clin Ther
|
2007
|
1.86
|
|
3
|
Fatty acids in cardiovascular health and disease: a comprehensive update.
|
J Clin Lipidol
|
2012
|
1.59
|
|
4
|
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
|
J Clin Lipidol
|
2011
|
1.45
|
|
5
|
The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels.
|
Postgrad Med
|
2009
|
1.44
|
|
6
|
Antiobesity effects of green tea catechins: a mechanistic review.
|
J Nutr Biochem
|
2010
|
1.29
|
|
7
|
Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects.
|
Nutr Metab (Lond)
|
2011
|
1.02
|
|
8
|
Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A(2) mass in statin-treated subjects with hypertriglyceridemia.
|
J Clin Lipidol
|
2009
|
1.02
|
|
9
|
Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin.
|
Mayo Clin Proc
|
2010
|
0.97
|
|
10
|
A review of calcium supplements and cardiovascular disease risk.
|
Adv Nutr
|
2012
|
0.94
|
|
11
|
Inclusion of guar gum and alginate into a crispy bar improves postprandial glycemia in humans.
|
J Nutr
|
2004
|
0.89
|
|
12
|
Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease.
|
Am J Cardiol
|
2009
|
0.89
|
|
13
|
Management of hypercholesterolaemia in postmenopausal women.
|
Drugs Aging
|
2002
|
0.87
|
|
14
|
Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model.
|
BMC Public Health
|
2014
|
0.86
|
|
15
|
A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.
|
Diabetes Technol Ther
|
2010
|
0.85
|
|
16
|
Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
|
J Gen Intern Med
|
2006
|
0.85
|
|
17
|
Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
|
Am Heart J
|
2006
|
0.84
|
|
18
|
Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes.
|
Nutrition
|
2008
|
0.83
|
|
19
|
Colesevelam hydrochloride powder for oral suspension versus cholestyramine powder for oral suspension: comparison of acceptability and tolerability.
|
Endocr Pract
|
2011
|
0.82
|
|
20
|
A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
|
Gynecol Obstet Invest
|
2005
|
0.82
|
|
21
|
Consumption of stearidonic acid-rich oil in foods increases red blood cell eicosapentaenoic acid.
|
J Acad Nutr Diet
|
2013
|
0.81
|
|
22
|
Serum lipid and antioxidant responses in hypercholesterolemic men and women receiving plant sterol esters vary by apolipoprotein E genotype.
|
J Nutr
|
2008
|
0.81
|
|
23
|
Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients.
|
Curr Med Res Opin
|
2010
|
0.81
|
|
24
|
Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects.
|
Clin Cardiol
|
2006
|
0.81
|
|
25
|
Hypocholesterolemic effects of plant sterols and stanols: Do the dose-response curves diverge?
|
Prostaglandins Leukot Essent Fatty Acids
|
2011
|
0.79
|
|
26
|
Novel developments in omega-3 fatty acid-based strategies.
|
Curr Opin Lipidol
|
2011
|
0.79
|
|
27
|
Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects.
|
J Cardiovasc Pharmacol
|
2009
|
0.78
|
|
28
|
Pullulan is a slowly digested carbohydrate in humans.
|
J Nutr
|
2003
|
0.78
|
|
29
|
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
|
Cardiovasc Drugs Ther
|
2012
|
0.77
|
|
30
|
Clinical predictors of glycosylated hemoglobin response to thiazolidinedione therapy.
|
Diabetes Technol Ther
|
2007
|
0.77
|
|
31
|
A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the "Back of the Line" as a therapy for dyslipidemia?
|
J Clin Lipidol
|
2008
|
0.77
|
|
32
|
Lipid management and the elderly.
|
Prev Cardiol
|
2003
|
0.76
|
|
33
|
Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
|
J Cardiometab Syndr
|
2006
|
0.76
|
|
34
|
Conclusions and recommendations from the symposium, Heart Healthy Omega-3s for Food: Stearidonic Acid (SDA) as a Sustainable Choice.
|
J Nutr
|
2012
|
0.75
|
|
35
|
Low-dose eicosapentaenoic acid and/or docosahexaenoic acid and triglyceride lowering.
|
Nutr Rev
|
2010
|
0.75
|
|
36
|
Physicians' personal intake and prescription of weight loss products: are we practicing what we preach?
|
Arch Intern Med
|
2004
|
0.75
|
|
37
|
Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
|
Expert Rev Cardiovasc Ther
|
2014
|
0.75
|
|
38
|
Planning a clinical trial.
|
J Clin Lipidol
|
2012
|
0.75
|
|
39
|
A softgel dietary supplement containing esterified plant sterols and stanols improves the blood lipid profile of adults with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled replication study.
|
J Acad Nutr Diet
|
2013
|
0.75
|